Peru struggles to contain hepatitis B outbreak:
This article was originally published in Clinica
Executive Summary
There has been a significant fall in the number of cases of hepatitis B reported so far this year in Peru, compared with the same period in 2001, but the health ministry remains on major alert. At the end of July 2002, the Peruvian health ministry's general office of epidemiology (OGE) reported 628 suspected cases, of which 356 had been confirmed, compared with 757 over the same period in 2001. The regions deemed at highest risk are Amazonas, Loreto, San Martin, Pasco, Ucayali, Cusco, Madre de Dios and Apurimac. The government has warned of the difficulty in diagnosing the disease and has launched a public awareness campaign and vaccination programme to help tackle the problem.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.